Research area · week to 3 Oct 2026

Economic and Financial Impacts of Cancer

Moving in The Lancet Oncology, medRxiv, BMJ, Cancer Cell, Nature Biotechnology, Nature Reviews Cancer, New England Journal of Medicine.

Moved this week: 0

Rebuilt 3 October 2026 at 4:06 pm AEST

Moved this week

Everything that moved →

Nothing in this area has moved yet this week.

Latest in Economic and Financial Impacts of Cancer

Newest first · last 60 days

Reflecting on 25 years of cancer research: transformative advances and unmet expectations.
Nature Reviews Cancer · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42711451
Open in JClub
Affordability in the era of precision oncology.
The Lancet Oncology · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790446
Open in JClub
Personalised medicine in oncology: inequality aversion in a fast-moving field.
The Lancet Oncology · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790450
Open in JClub
Inequities in access to precision oncology: shared challenges, unified blueprint.
The Lancet Oncology · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790447
Open in JClub
Charity Care, Uncompensated Care, and Medicaid Patient Volume Among 340B and Non-340B Hospitals
medRxiv · 29 Sept 2026 · Preprint
Read the brief in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.02.12.26346191
Open in JClub
Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study.
The Lancet Oncology · 25 Sept 2026 · Journal Article
Lower-GDP countries have significantly reduced uptake of essential cancer medicines, especially those requiring complex genomic diagnostics, with the lowest access observed in low-income regions.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790449
Open in JClub
Frailty, initial attrition and feasibility of novel platinum-free options for advanced non-small-cell lung cancer in the real-world setting
medRxiv · 3 Sept 2026 · Preprint
Read the brief in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.02.02.26345340
Open in JClub
Lessons from drug revenue life cycles: distributions across modalities and therapeutic areas.
Nature Biotechnology · 1 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42613383
Open in JClub
Pancreatic cancer: US approves "breakthrough" drug that may double survival time.
BMJ · 27 Aug 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42660599
Open in JClub
Rethinking the Role of Pay for Performance in Federal Health Care Quality Programs.
New England Journal of Medicine · 13 Aug 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42573389
Open in JClub
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative.
Cancer Cell · 10 Aug 2026 · Published Erratum
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42456654
Open in JClub

Follow this area in the app

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read

Moved this week

Latest in Economic and Financial Impacts of Cancer

Browse JClub